Dark Blue is a UK-based biotech company that is advancing first-in-class small molecule protein degraders targeting MLLT1/3 proteins in acute myeloid leukemia (AML)
This prevents ApoE from interacting with the LDLR and LDL-related protein 1 on hepatocytes
The second runs through RAS, RAF, MEK, and ERK1/2, which control cell-cycle entry and satellite-cell proliferation [5]
Chit xut ca cc loi qu Lu, V ty, Du tm, Ngn hnh gip chng oxi hoa, tng sc khng cho da gip da c tr ha duy tr ln da tr trung
Chemically prepared fats and Crohn disease: a pilot study of the occurrence of trans-fatty acids in the subcutaneous tissue of Crohn patients in comparison with healthy controls as a parameter of long-term fat intake
Postoperative Serotonin Syndrome: A Case Report Highlighting Dexmedetomidine for Refractory Symptoms